Continuing Advances in mBC: Optimizing CDK4&6 Inhibitor Treatment Outcomes
We are pleased to invite you for the next MBC TALKS webinar and live Q&A session where Prof. Eva Ciruelos, Prof. Marc Thill and Maria Noblet R.N. will discuss different CDK4&6i trials from an endocrine resistance perspective.